Postoperative insulin resistance and the intestinal microbiota: mechanisms and research advances.

IF 5.2
Microbiome research reports Pub Date : 2025-09-25 eCollection Date: 2025-01-01 DOI:10.20517/mrr.2025.54
Feng Lin, Minzhi Sun, Xiao Yuan, Yujie Cai, Wenjing Chen, Siyu Liu, Zhipeng He
{"title":"Postoperative insulin resistance and the intestinal microbiota: mechanisms and research advances.","authors":"Feng Lin, Minzhi Sun, Xiao Yuan, Yujie Cai, Wenjing Chen, Siyu Liu, Zhipeng He","doi":"10.20517/mrr.2025.54","DOIUrl":null,"url":null,"abstract":"<p><p>Postoperative insulin resistance (PIR) is a common metabolic complication that significantly affects patient recovery and long-term outcomes. Recent studies have revealed a robust association between the gut microbiota and PIR, underscoring the potential role of microbial communities in modulating insulin sensitivity. In this comprehensive review, we synthesize current literature on the interplay between PIR and the gut microbiota, delve into the underlying mechanisms linking the two, and provide an overview of recent research progress in this field. Evidence suggests that the gut microbiota may influence PIR through mechanisms involving metabolic endotoxins, short-chain fatty acids, branched-chain amino acids, and other metabolites. Overall, the gut microbiota plays a crucial role in the onset and progression of PIR. This review aims to provide a theoretical basis for developing PIR intervention strategies based on microbiome regulation.</p>","PeriodicalId":94376,"journal":{"name":"Microbiome research reports","volume":"4 3","pages":"36"},"PeriodicalIF":5.2000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12540045/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbiome research reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20517/mrr.2025.54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Postoperative insulin resistance (PIR) is a common metabolic complication that significantly affects patient recovery and long-term outcomes. Recent studies have revealed a robust association between the gut microbiota and PIR, underscoring the potential role of microbial communities in modulating insulin sensitivity. In this comprehensive review, we synthesize current literature on the interplay between PIR and the gut microbiota, delve into the underlying mechanisms linking the two, and provide an overview of recent research progress in this field. Evidence suggests that the gut microbiota may influence PIR through mechanisms involving metabolic endotoxins, short-chain fatty acids, branched-chain amino acids, and other metabolites. Overall, the gut microbiota plays a crucial role in the onset and progression of PIR. This review aims to provide a theoretical basis for developing PIR intervention strategies based on microbiome regulation.

Abstract Image

术后胰岛素抵抗与肠道菌群:机制及研究进展。
术后胰岛素抵抗(PIR)是一种常见的代谢并发症,显著影响患者的康复和长期预后。最近的研究揭示了肠道微生物群与PIR之间的密切联系,强调了微生物群落在调节胰岛素敏感性方面的潜在作用。在这篇综述中,我们综合了目前关于PIR与肠道微生物群相互作用的文献,深入探讨了两者之间的潜在机制,并概述了该领域的最新研究进展。有证据表明,肠道微生物群可能通过代谢内毒素、短链脂肪酸、支链氨基酸和其他代谢物的机制影响PIR。总的来说,肠道微生物群在PIR的发生和发展中起着至关重要的作用。本文旨在为制定基于微生物组调控的PIR干预策略提供理论依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.80
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书